GlassScriptPhysician profile
Pavlo I Netrebko
NPI 1629240395
$16,673.13
in general payments reported to CMS, 2019-2025
39 companies · $2,172 in 2025
The $2,172 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $443 · 2021: $502 · 2022: $1,003 · 2023: $653 · 2024: $684 · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,422 · Travel and Lodging: $1,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,421.69 |
| Travel and Lodging | $1,087.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $9,937.37 | 2019-2025 | Qdot Micro Catheter, Carto 3 |
| Abbott Laboratories | $1,765.30 | 2020-2025 | Aveir, Amplatzer Amulet, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $994.98 | 2019-2025 | Lifevest |
| Biotronik INC. | $524.63 | 2019-2025 | Amvia Edge, Selectra |
| Medtronic, INC. | $362.37 | 2021-2024 | Micra, Tyrx |
| Janssen Pharmaceuticals, INC | $332.65 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $271.54 | 2019-2025 | Camzyos |
| Amgen INC. | $259.13 | 2019-2025 | Repatha, Repatha |
| Elutia, INC. | $221.28 | 2019-2025 | Ecm Patch,Pouch |
| Novartis Pharmaceuticals Corporation | $214.96 | 2019-2025 | |
| United Therapeutics Corporation | $174.76 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.69 | 2019-2025 | Jardiance |
| Braemar Manufacturing, LLC | $149.13 | 2019 | |
| Edwards Lifesciences Corporation | $145.85 | 2019 | |
| Boston Scientific Corporation | $126.10 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor, Farapulse |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $109.69 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $106.08 | 2019-2025 | Lokelma, Farxiga |
| Esperion Therapeutics, INC. | $98.22 | 2020-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $82.02 | 2019-2020 | |
| Davol INC. | $75.94 | 2021-2024 | |
| Impulse Dynamics (USA) INC. | $63.27 | 2023 | Optimizer |
| Novo Nordisk INC | $53.24 | 2019-2025 | Wegovy |
| Heartflow, INC. | $48.45 | 2023-2025 | Ffrct |
| Infobionic, INC | $43.60 | 2021-2023 | Mome Kardia |
| Atricure, INC. | $40.76 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Cardiva Medical, INC. | $38.01 | 2020-2024 | Optowire |
| Kestra Medical Technology Services, INC. | $37.71 | 2023 | Assure Wcd |
| Baxter Healthcare | $33.95 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Celgene Corporation | $32.04 | 2022-2023 | Camzyos |
| Medtronic Vascular, INC. | $30.72 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $25.06 | 2023 | Uptravi, Opsumit |
| Chiesi USA, INC. | $17.38 | 2020 | |
| Lundbeck LLC | $17.24 | 2019 | |
| Abiomed | $16.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.85 | 2019 | |
| Philips North America LLC | $13.94 | 2022 | |
| Cardiofocus, INC. | $12.81 | 2020 | |
| Medtronic USA, INC. | $11.51 | 2020 | |
| Irhythm Technologies, INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavlo Netrebko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.